Publication | Closed Access

Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: A randomized controlled trial

PsychiatryPsychotic DisorderPsychotropic MedicationCognitive DysfunctionMirtazapine Augmentation EnhancesPsychologySchizophreniaNeuropharmacologyPsychopharmacologySchizophrenia PatientsReduces Negative SymptomsSocial SciencesBiological PsychiatryMedicinePsychopathology